Journal article · 2025 · Open access

Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition

Naisheng Zheng, Fuli Li, Qing Huang, Xian Huang, Tomasz Maj

Redox Biology, 86, 103826 · Published 18 August 2025 · DOI 10.1016/j.redox.2025.103826

Open full textCite this paper

In brief

“Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition” is a 2025 journal article by Naisheng Zheng and 4 co-authors, published in Redox Biology. OpenAlex counts 30 citations as of 21 November 2026, which puts it in the top 5% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Redox Biology.

Citations
30
Most cited in
2026 (27)
Field-weighted impact
7.41
References
70
Authors
5

Abstract

Ferroptosis has emerged as a promising therapeutic target in cancer therapy, with the tumor microenvironment (TME) playing a pivotal role in regulating ferroptosis. Although macrophages contribute to ferroptosis regulation within TME, the underlying mechanisms remain unclear. In this study, we demonstrate that macrophages consistently attenuate GPX4 inhibitor-induced lipid peroxidation and cell death in various tumor cell lines, whereas their resistance to cysteine transport inhibitor-triggered ferroptosis varies across cell types. This tumor protection from ferroptosis is mediated through macrophage-tumor cell contact and the delivery of macrophage-derived extracellular vesicles (Mφ-EV). Transcriptomic and proteomic analyses revealed that macrophages and Mφ-EV enhance glutathione metabolism in tumor cells. Notably, Mφ-EV are uniquely enriched with the glutathione metabolism-related protein PRDX6. Mechanistically, the glutathione peroxidase activity of PRDX6 elevates intracellular reduced glutathione, suppresses lipid peroxidation, and thereby mitigates ferroptosis. Furthermore, macrophage-derived PRDX6 reduces mitochondrial superoxide accumulation, alleviates ferroptosis-induced mitophagy, and enhances tumor cell viability, ultimately promoting tumor growth. Together, our findings provide a novel mechanism of ferroptosis resistance in TME, wherein macrophages confer tumor cell resilience by bypassing GPX4 inhibition.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zheng, N., Li, F., Huang, Q., Huang, X., & Maj, T. (2025). Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition. Redox Biology, 86, 103826. https://doi.org/10.1016/j.redox.2025.103826

MLA 9

Zheng, Naisheng, et al. “Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition.” Redox Biology, vol. 86, 2025, p. 103826. https://doi.org/10.1016/j.redox.2025.103826.

Chicago

Zheng, Naisheng, Fuli Li, Qing Huang, Xian Huang, and Tomasz Maj. 2025. “Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition.” Redox Biology 86: 103826. https://doi.org/10.1016/j.redox.2025.103826.

Harvard

Zheng, N. et al. (2025) ‘Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition’, Redox Biology, 86, p. 103826. doi:10.1016/j.redox.2025.103826.

IEEE

N. Zheng, F. Li, Q. Huang, X. Huang, and T. Maj, “Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition,” Redox Biology, vol. 86, p. 103826, 2025, doi: 10.1016/j.redox.2025.103826.

BibTeX

@article{zheng2025macrophages,
  title     = {{Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition}},
  author    = {Zheng, Naisheng and Li, Fuli and Huang, Qing and Huang, Xian and Maj, Tomasz},
  journal   = {Redox Biology},
  year      = {2025},
  volume    = {86},
  pages     = {103826},
  doi       = {10.1016/j.redox.2025.103826},
  url       = {https://doi.org/10.1016/j.redox.2025.103826}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis

  • ferroptosis resistance
  • tumor-associated macrophages
  • peroxiredoxin 6
  • glutathione metabolism
  • GPX4 inhibition
  • lipid peroxidation
  • mitophagy
  • mitochondrial superoxide

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zheng, N., Li, F., Huang, Q., Huang, X., & Maj, T. (2025). Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition. Redox Biology, 86, 103826. https://doi.org/10.1016/j.redox.2025.103826

How many times has this paper been cited?

30 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Redox Biology: sign in and open the full text from this page.

Who wrote this paper?

Naisheng Zheng, Fuli Li, Qing Huang, Xian Huang, Tomasz Maj.

What is the DOI of this paper?

10.1016/j.redox.2025.103826, permanently at https://doi.org/10.1016/j.redox.2025.103826. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.